Cochrane Abstracts
Rofecoxib for rheumatoid arthritis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rofecoxib for Rheumatoid Arthritis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431075/all/Rofecoxib_for_rheumatoid_arthritis.
Rofecoxib for rheumatoid arthritis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431075/all/Rofecoxib_for_rheumatoid_arthritis. Accessed October 30, 2025.
Rofecoxib for rheumatoid arthritis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431075/all/Rofecoxib_for_rheumatoid_arthritis
Rofecoxib for Rheumatoid Arthritis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 October 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431075/all/Rofecoxib_for_rheumatoid_arthritis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rofecoxib for rheumatoid arthritis
ID - 431075
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431075/all/Rofecoxib_for_rheumatoid_arthritis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
